UST, uronyl 2-sulfotransferase, 10090

N. diseases: 17; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.300 Biomarker disease CTD_human Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. 30061737 2018
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.300 Biomarker disease CTD_human Multi-ethnic genome-wide association study for atrial fibrillation. 29892015 2018
CUI: C0235480
Disease: Paroxysmal atrial fibrillation
Paroxysmal atrial fibrillation
0.300 Biomarker disease CTD_human Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. 30061737 2018
CUI: C0235480
Disease: Paroxysmal atrial fibrillation
Paroxysmal atrial fibrillation
0.300 Biomarker disease CTD_human Multi-ethnic genome-wide association study for atrial fibrillation. 29892015 2018
CUI: C2585653
Disease: Persistent atrial fibrillation
Persistent atrial fibrillation
0.300 Biomarker phenotype CTD_human Multi-ethnic genome-wide association study for atrial fibrillation. 29892015 2018
CUI: C2585653
Disease: Persistent atrial fibrillation
Persistent atrial fibrillation
0.300 Biomarker phenotype CTD_human Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. 30061737 2018
CUI: C3468561
Disease: familial atrial fibrillation
familial atrial fibrillation
0.300 Biomarker phenotype CTD_human Multi-ethnic genome-wide association study for atrial fibrillation. 29892015 2018
CUI: C3468561
Disease: familial atrial fibrillation
familial atrial fibrillation
0.300 Biomarker phenotype CTD_human Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. 30061737 2018
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.300 Biomarker disease CTD_human Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. 20864642 2011
CUI: C0269102
Disease: Endometrioma
Endometrioma
0.300 Biomarker disease CTD_human Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. 20864642 2011
CUI: C0005890
Disease: Body Height
Body Height
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.100 GeneticVariation group GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148 2017
CUI: C0337443
Disease: Sodium measurement
Sodium measurement
0.100 GeneticVariation phenotype GWASCAT Genome-Wide Gene-Sodium Interaction Analyses on Blood Pressure: The Genetic Epidemiology Network of Salt-Sensitivity Study. 27271309 2016
CUI: C0428883
Disease: Diastolic blood pressure
Diastolic blood pressure
0.100 GeneticVariation phenotype GWASCAT Genome-Wide Gene-Sodium Interaction Analyses on Blood Pressure: The Genetic Epidemiology Network of Salt-Sensitivity Study. 27271309 2016
CUI: C0523465
Disease: Serum albumin measurement
Serum albumin measurement
0.100 GeneticVariation phenotype GWASDB Genome-wide association study identifies multiple loci influencing human serum metabolite levels. 22286219 2012
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.040 Biomarker disease BEFREE Ustekinumab [UST] was recently approved in Europe for the treatment of moderate to severe Crohn's disease [CD]. 30989232 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.040 Biomarker disease BEFREE A systematic review of the available RWE studies of UST for CD and pooled analysis of the available effectiveness and safety data was performed. 31202609 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.040 Biomarker disease BEFREE Ustekinumab [UST] therapy during pregnancy has not yet been extensively evaluated in patients with Crohn's disease. 30388211 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.040 Biomarker disease BEFREE Ustekinumab [UST] is effective in the treatment of adults with moderate to severe Crohn's disease [CD]. 30541021 2019
CUI: C0003862
Disease: Arthralgia
Arthralgia
0.010 Biomarker phenotype BEFREE No impact of UST on arthralgia was observed in patients with concomitant ankylosing spondylitis [n = 17]. 30989232 2019
CUI: C0021125
Disease: Impulsive Behavior
Impulsive Behavior
0.010 Biomarker phenotype BEFREE In summary, UST exposure during adolescence induced long-term impairments in impulsivity and compulsivity, whereas CST had only minor effects. 30816288 2019
CUI: C0038013
Disease: Ankylosing spondylitis
Ankylosing spondylitis
0.010 Biomarker disease BEFREE No impact of UST on arthralgia was observed in patients with concomitant ankylosing spondylitis [n = 17]. 30989232 2019
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.010 Biomarker disease BEFREE Positive staining rates for anabolic enzymes CHST-3, CHST-12, CHST-15, and UST were lower in the KBD and OA groups than those in the control group. 28274888 2017
CUI: C2745963
Disease: Kashin-Beck Disease
Kashin-Beck Disease
0.010 Biomarker disease BEFREE Positive staining rates for anabolic enzymes CHST-3, CHST-12, CHST-15, and UST were lower in the KBD and OA groups than those in the control group. 28274888 2017